Clinical trials: Rheumatoid Arthritis-Associated Interstitial Lung Disease
Rheumatoid Lung, Rheumatoid Arthritis
Rheumatoid Arthritis-Associated Interstitial Lung Disease: Characterization of Lung Disease Progression
BERTHA study´s primary objective is to characterize Rheumatoid Arthritis-associated Interstitial Lung Disease (RA-ILD) progression and to define a combination of biomarkers, genetic and clinical variables capable of identifying…
- Conditions
- Rheumatoid Lung, Rheumatoid Arthritis, Interstitial Lung Disease, Pulmonary Fibrosis
- Trial name
- BERTHA (NCT04136223)
- Where
- 5 sites in Brazil
- Volunteers
- 100 people
- Sponsor
- Hospital do Coracao
Rheumatoid Arthritis-Associated Interstitial Lung Disease
Value of KL-6 in Rheumatoid Arthritis-Associated ILD
Evaluation of serum KL6 level in rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
- Trial name
- NCT05979454
- Testing
- Krebs von den Lungen-6 (KL6)
- Where
- Egypt
- Volunteers
- 80 people
- Sponsor
- Assiut University
Respiratory Muscle Strength, Oxygen Saturation
Prediction of Pulmonary Problems
The aim of this study was to examine the relationship between respiratory muscle strength and grip strength, muscle strength, oxygen saturation of peripheral muscles, dyspnea and respiration, cough, and health-related quality of…
- Conditions
- Respiratory Muscle Strength, Oxygen Saturation, Rheumatoid Arthritis (RA)
- Trial name
- NCT07047391
- Where
- Turkey (Türkiye)
- Volunteers
- 24 people
- Sponsor
- Zülal TATAR
Rheumatoid Arthritis, Ankylosing Spondylitis
PatientSpot Formerly Known as ArthritisPower
Patient Power is a patient research network and database (registry) to collect prospective information about demographics, self-reported diagnoses and medications, and willingness to participate in research from participants with…
- Conditions
- Rheumatoid Arthritis, Ankylosing Spondylitis, Fibromyalgia, Gout
- Trial name
- NCT03840928
- Where
- United States
- Volunteers
- 40,000 people, healthy volunteers welcome
- Sponsor
- Global Healthy Living Foundation
Rheumatic Disease
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
The purpose of this study is to assess the incidence of rheumatologic flares, changes in pain scores (VAS), changes in functional outcomes (PROMIS), wound complications, surgical site infections, and return trips to the operating…
- Trial name
- NCT07138898
- Testing
- Methotrexate, Sulfasalazine, Hydroxychloroquine
- Where
- United States
- Volunteers
- 80 people
- Sponsor
- NYU Langone Health
Rheumatoid Arthritis, Interstitial Lung Disease
Novel Biomarkers in Assessment of Interstitial Lung Disease Associated With Rheumatoid Arthritis Patients
Assess Krebs von den Lungen-6 (KL-6) and Calprotectin as novel biomarkers for diagnosis of ILD among Rheumatoid arthritis patients
- Trial name
- NCT07003451
- Testing
- Calprotectin Level
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- Assiut University
Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA)
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
The goal of this clinical trial is to evaluate whether the live attenuated tetravalent Butantan-Dengue vaccine (Butantan-DV) is safe and capable of inducing an immune response in patients aged 12 to 59 years with autoimmune…
- Conditions
- Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA), Systemic Lupus Erythematosus (SLE), Juvenile Systemic Lupus Erythematosus
- Trial name
- BTNDV-ARD (NCT07087912)
- Testing
- Dengue 1,2,3,4 (attenuated) vaccine
- Where
- 2 sites in Brazil
- Volunteers
- 477 people, healthy volunteers welcome
- Sponsor
- University of Sao Paulo General Hospital
Rheumatoid Arthritis, Interstitial Lung Disease
Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2
The overall goal of this study is to identify risk and prognosis factors of Interstitial Lung Disease (ILD) in patients with rheumatoid arthritis (RA).
- Trial name
- TRANSLATE2 (NCT04227535)
- Where
- France
- Volunteers
- 509 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Chronic Obstructive Pulmonary Disease (COPD), Smoking
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
The purpose of this study is to obtain biologic materials from the blood, airways and/or urine of normal individuals and individuals with lung disease.
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD), Smoking, Smoking Cessation, Idiopathic Pulmonary Fibrosis (IPF)
- Trial name
- NCT01776398
- Where
- United States
- Volunteers
- 2,000 people, healthy volunteers welcome
- Sponsor
- Weill Medical College of Cornell University
Rheumatoid Arthritis-Associated Interstitial Lung Disease
Rheumatoid Arthritis-associated Interstitial Lung Disease Definition
This is a prospective multicenter study in southern Belgium to determine the prevalence and incidence of interstitial lung disease in patients with rheumatoid arthritis (RA).
- Trial name
- RAID (NCT06184893)
- Where
- Belgium
- Volunteers
- 250 people
- Sponsor
- Centre Hospitalier Universitaire de Liege
Rheumatoid Arthritis Associated Interstitial Lung Disease
Treatment Strategy for Patients With RA-ILD
This is a 52-week, multicenter, prospective, open-label, randomized controlled clinical study, comparing the efficacy and safety of tocilizumab, rituximab, and csDMARD methotrexate in patients with RA-ILD.
- Trial name
- NCT07643038
- Testing
- Tocilizumab, Rituximab (RTX), Methotrexate
- Where
- 22 sites in China
- Volunteers
- 204 people
- Sponsor
- Chinese SLE Treatment And Research Group
Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified Elsewhere, Systemic Sclerosis Pulmonary
Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases
The RMD-mILDer trial is a home monitoring strategy trial aiming to improve management of interstitial lung disease related to rheumatic diseases applying eHealth technology.
- Conditions
- Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified Elsewhere, Systemic Sclerosis Pulmonary, Dermatomyositis, Rheumatoid Arthritis
- Trial name
- RMD-mILDer (NCT06732674)
- Testing
- A home monitoring strategy with event driven management
- Where
- Norway
- Volunteers
- 218 people
- Sponsor
- Oslo University Hospital
Rheumatoid Arthritis, Interstitial Pneumonia
Rituximab in Rheumatoid Arthritis Lung Disease
This study will examine the course of patients with progressive rheumatoid arthritis associated interstitial lung disease (RA-ILD) treated with rituximab for safety and progression-free survival at 48 weeks.
- Trial name
- NCT00578565
- Testing
- Rituximab
- Where
- 2 sites in United States
- Volunteers
- 10 people
- Sponsor
- Eric Matteson